Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 277, Issue 18, Pages 16147-16152Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112363200
Keywords
-
Categories
Funding
- NICHD NIH HHS [HD27262, T32-HD07183] Funding Source: Medline
Ask authors/readers for more resources
Glycogen synthase kinase-3beta (GSK-3) is a key downstream target of Wnt signaling and is regulated by its interactions with activating and inhibitory proteins. We and others have shown that GSK-3 activity toward nonprimed substrates is regulated in part through a competition between its activating (Axin) and inhibitory (GBP/ FRAT) binding partners. Here we use a reverse two-hybrid screen to identify mutations in GSK-3 that alter binding to GBP and Axin. We find that these mutations overlap and propose that GBP and Axin compete for binding to the same region of GSK-3. We use these mutations to examine the ability of GSK-3 to block eye development in Xenopus embryos and suggest that GSK-3 regulates eye development through a non-Wnt pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available